9/20/2013 7:15:50 AM
AstraZeneca PLC ( AZN ) and Bristol-Myers Squibb Co. ( BMY ) have recalled about 92,000 vials of their jointly marketed Type 2 diabetes treatment Bydureon in several European countries because some vials weren't fully filled with the long- acting medication. The affected batches were recalled in the U.K., Germany, Romania, the Netherlands, Ireland, Sweden, Finland and Spain, said a Bristol-Myers spokesman. No batches distributed in other markets were affected and the companies don't expect any supply issues, he said.
Help employers find you! Check out all the jobs and post your resume.
comments powered by